Abstract
Clinical Outcomes of Patients (pts) with TP53-Mutated Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS): A Single Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have